Biogen Inc.
(NASDAQ : BIIB)

( )
BIIB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Like Small Cap Stocks < $20?
You should, we just banked a 30% winner in 2 days!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
CELGCelgene Corporation
0.27%93.671.3%$1008.13m
BIIBBiogen Inc.
-0.09%230.001.3%$686.47m
AMGNAmgen Inc.
0.00%179.761.3%$470.05m
GILDGilead Sciences, Inc.
0.00%63.040.9%$441.53m
ILMNIllumina, Inc.
0.26%322.883.5%$285.89m
REGNRegeneron Pharmaceuticals, Inc.
0.83%347.002.6%$277.64m
VRTXVertex Pharmaceuticals Incorporated
4.07%175.371.9%$247.10m
ALXNAlexion Pharmaceuticals, Inc.
-0.28%132.002.0%$174.70m
EXASExact Sciences Corporation
3.61%93.9425.3%$160.74m
SRPTSarepta Therapeutics, Inc.
0.00%118.0914.7%$144.55m
AAgilent Technologies, Inc.
-0.04%75.541.6%$142.04m
ONCESpark Therapeutics, Inc.
0.00%110.6011.2%$133.55m
INCYIncyte Corporation
2.38%75.412.5%$98.69m
IONSIonis Pharmaceuticals, Inc.
0.00%75.008.3%$95.31m
BMRNBioMarin Pharmaceutical Inc.
0.00%86.004.3%$93.68m

Company Profile

Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. It offers TECFIDERA, AVONEX, PLEGRIDY, TYSABRI, ZINBRYTA, and FAMPYRA for the treatment of multiple sclerosis; SPINRAZA for the treatment of spinal muscular atrophy; and FUMADERM for the treatment of severe plaque psoriasis. The company was founded by Charles Weissmann, Heinz Schaller, Kenneth Murray, Walter Gilbert, and Phillip Allen Sharp in 1978 and is headquartered in Cambridge, MA.